News

qTOWER³ FDA EUA for COVID-19 Testing

19.11.2020 | ニュース

Analytik Jena’s qTOWER³ qPCR Authorized Under FDA EUA for COVID-19 Testing with PerkinElmer New Coronavirus Nucleic Acid Detection Kit

[Translate to Japanese:] Friday, November 13, 2020 – Upland, California – Analytik Jena, a world leader in liquid handling, sample processing automation and nucleic acid amplification technologies announced today that the US Food and Drug Administration (FDA) has expanded the PerkinElmer emergency use authorization (EUA) for the PerkinElmer New Coronavirus Nucleic Acid Detection Kit to include the Analytik Jena qTOWER3 / qTOWER3 G 96 Real-Time PCR Systems and qTOWER3 84 / qTOWER3 84 G Real-Time PCR System.

The PerkinElmer New Coronavirus Nucleic Acid Detection Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in human oropharyngeal, nasopharyngeal, and anterior nasal swab samples. Using the FDA SARS-CoV-2 Reference Panel for comparative assessment, the PerkinElmer New Coronavirus Nucleic Acid Detection kit showed the lowest limit of detection (LoD) on the market.

As noted by Dr. Monde Qhobosheane, President and CEO of Analytik Jena US, “With the surge in COVID-19 cases throughout the world and in particular the United States, scalable high throughput, fast turnaround and competitively priced testing is critical to reducing the spread of COVID-19 and helping businesses, schools and the general economy fully re-open. The expanded EUA makes multiplexed automation friendly and scalable nucleic acid-based diagnostics readily available to give a variety of throughput options for both small and large clinical laboratory operations.”

For further information on the qTOWER3 Real-Time PCR system, PerkinElmer New Coronavirus Nucleic Acid Detection Kit or any other general inquiries, please reach out to Analytik Jena US LLC at info@us.analytik-jena.com.

Analytik Jena is a provider of high-end analytical measuring technology, of instruments and products in the fields of biotechnology and molecular diagnostics, as well as of high quality liquid handling and automation technologies.


Contact

Hanna Engelhardt
Media Relations Life Science
+49 (0) 36 41  77-73 55press@analytik-jena.com

The newsletter of Analytik Jena frequently keeps you posted about:

Sign up here